A comparative analysis on the latest international and local guidelines for the management of hypertension.
作者信息
Leow Aloysius Sheng-Ting, Sule Ashish Anil, Tay Jam Chin, Teong Hui Hwang, Moy Wai Lun, Handa Pankaj Kumar, Wu Yik Tian, Chadachan Veerendra Melagireppa, Oh Vernon Min Sen, Sia Ching-Hui, Poh Kian-Keong, Teo Boon Wee, Puar Troy H
机构信息
Department of Medicine, National University Hospital, Singapore.
Department of General Medicine, Tan Tock Seng Hospital, Singapore.
出版信息
Singapore Med J. 2025 May 1;66(5):240-243. doi: 10.4103/singaporemedj.SMJ-2025-094. Epub 2025 May 19.
Abstract
摘要
相似文献
1
A comparative analysis on the latest international and local guidelines for the management of hypertension.高血压管理的最新国际和本地指南的比较分析
Singapore Med J. 2025 May 1;66(5):240-243. doi: 10.4103/singaporemedj.SMJ-2025-094. Epub 2025 May 19.
2
Comparison between the world health organization (WHO) and international society of hypertension (ISH) guidelines for hypertension.世界卫生组织 (WHO) 与国际高血压学会 (ISH) 高血压指南比较。
Ann Med. 2022 Dec;54(1):837-845. doi: 10.1080/07853890.2022.2044510.
3
Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee.1993年世界卫生组织-国际高血压学会轻度高血压管理指南摘要。世界卫生组织/国际高血压学会轻度高血压联络委员会小组委员会。
BMJ. 1993 Dec 11;307(6918):1541-6. doi: 10.1136/bmj.307.6918.1541.
4
Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines.印度尼西亚肺动脉高压：当前状况和国际指南的本土化应用。
Glob Heart. 2021 Apr 20;16(1):23. doi: 10.5334/gh.944.
5
[European guidelines for the management of arterial hypertension 2018-what has changed?].[2018年欧洲动脉高血压管理指南——有哪些变化？]
Internist (Berl). 2019 Feb;60(2):202-208. doi: 10.1007/s00108-018-0552-9.
6
Guidelines for the Management of Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension.肝硬化门静脉高压症食管胃底静脉曲张出血的管理指南
J Clin Transl Hepatol. 2023 Dec 28;11(7):1565-1579. doi: 10.14218/JCTH.2023.00061. Epub 2023 Oct 17.
7
Adapting a national guideline for local use: a comparative case study in a US and an Israeli health maintenance organization.调整国家指南以供地方使用：美国和以色列一家健康维护组织的比较案例研究
J Health Serv Res Policy. 2000 Jul;5(3):148-55. doi: 10.1177/135581960000500305.
8
Outpatient management of essential hypertension: a review based on the latest clinical guidelines.原发性高血压的门诊管理：基于最新临床指南的综述。
Ann Med. 2024 Dec;56(1):2338242. doi: 10.1080/07853890.2024.2338242. Epub 2024 Apr 11.
9
Editors' Commentary on the 2023 ESH Management of Arterial Hypertension Guidelines.编辑对 2023 年ESH 动脉高血压管理指南的评论。
Hypertension. 2023 Sep;80(9):1795-1799. doi: 10.1161/HYPERTENSIONAHA.123.21592. Epub 2023 Jun 24.
10
Advances in Hypertension Management: Insights from the Latest European Guidelines.高血压管理的进展：来自最新欧洲指南的见解
J Cardiovasc Dev Dis. 2025 Apr 14;12(4):155. doi: 10.3390/jcdd12040155.
本文引用的文献
1
Primary Technology-Enhanced Care for Hypertension Scaling Program: Trial-Based Economic Evaluation Examining Effectiveness and Cost-Effectiveness Using Real-World Data in Singapore.高血压初级技术强化护理扩展项目：在新加坡使用真实世界数据进行基于试验的经济评估，考察有效性和成本效益。
J Med Internet Res. 2025 Apr 15;27:e59275. doi: 10.2196/59275.
2
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.2型糖尿病患者的强化血压控制
N Engl J Med. 2025 Mar 27;392(12):1155-1167. doi: 10.1056/NEJMoa2412006. Epub 2024 Nov 16.
3
Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.在伴有或不伴有糖尿病或既往卒中的心血管高危患者中，将收缩压降低至 120mmHg 以下与降低至 140mmHg 以下：一项开放标签、盲法结局、随机试验。
Lancet. 2024 Jul 20;404(10449):245-255. doi: 10.1016/S0140-6736(24)01028-6. Epub 2024 Jun 27.
4
Atherosclerotic cardiovascular disease landscape in Singapore.新加坡的动脉粥样硬化性心血管疾病概况
Front Cardiovasc Med. 2024 Apr 24;11:1342698. doi: 10.3389/fcvm.2024.1342698. eCollection 2024.
5
Prolonged Hypokalemia and Delayed Diagnosis of Primary Aldosteronism: Clinical Course and Risk Factors.原发性醛固酮增多症的长期低钾血症和延迟诊断：临床过程和危险因素。
J Clin Endocrinol Metab. 2024 Jul 12;109(8):e1574-e1581. doi: 10.1210/clinem/dgad752.
6
Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial.用洛鲁司他抑制醛固酮合酶治疗未控制的高血压：TARGET-HTN 随机临床试验。
JAMA. 2023 Sep 26;330(12):1140-1150. doi: 10.1001/jama.2023.16029.
7
Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial.在老年护理机构中通过盐替代和限制盐供应来降低血压：一项整群随机试验。
Nat Med. 2023 Apr;29(4):973-981. doi: 10.1038/s41591-023-02286-8. Epub 2023 Apr 13.
8
Implementation and use of technology-enabled blood pressure monitoring and teleconsultation in Singapore's primary care: a qualitative evaluation using the socio-technical systems approach.利用技术实现的血压监测和远程咨询在新加坡初级保健中的实施和使用：采用社会技术系统方法进行的定性评估。
BMC Prim Care. 2023 Mar 16;24(1):71. doi: 10.1186/s12875-023-02014-8.
9
Global mean potassium intake: a systematic review and Bayesian meta-analysis.全球平均钾摄入量：系统评价和贝叶斯荟萃分析。
Eur J Nutr. 2023 Aug;62(5):2027-2037. doi: 10.1007/s00394-023-03128-6. Epub 2023 Mar 8.
10
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.巴多司他治疗顽固性高血压的2期试验。
N Engl J Med. 2023 Feb 2;388(5):395-405. doi: 10.1056/NEJMoa2213169. Epub 2022 Nov 7.
Zotero 插件